Skip to content
  • Sunday, 26 July 2026
  • 1:46 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Cellares and Papillon Therapeutics Partner to Automate Manufacturing of Investigational Therapy for Friedreich’s Ataxia
Pharmaceutical R&D

Cellares and Papillon Therapeutics Partner to Automate Manufacturing of Investigational Therapy for Friedreich’s Ataxia

Teuku Ryan Jul 23, 2026 0

In a significant development for the rare disease community, Cellares and Papillon Therapeutics have announced a strategic collaboration aimed at…

Read More
Data Science & Bioinformatics

Agentic Workflows to Automate Your Data Science Pipeline

Evan Lee Salim Jul 4, 2026 0

The modern data science landscape is undergoing a significant transformation, driven by the imperative to increase efficiency and strategic impact.…

Read More
Data Science & Bioinformatics

Agentic Workflows to Automate Your Data Science Pipeline

Evan Lee Salim Jun 27, 2026 0

The modern data science landscape is increasingly characterized by complexity and scale, yet a significant portion of a data scientist’s…

Read More
Data Science & Bioinformatics

Revolutionizing Document Management: Five Python Scripts Automate Tedious PDF Tasks for Enhanced Efficiency and Security

Evan Lee Salim Jun 16, 2026 0

In an increasingly digital world, Portable Document Format (PDF) files remain an indispensable medium for information exchange across virtually every…

Read More
Laboratory Automation & Robotics

Cellares Raises $257M Series D to Automate Cell Therapy Manufacturing

Lana Keisha Mar 24, 2026 0

The burgeoning field of cell and gene therapy, heralded as a revolutionary frontier in medicine, is currently grappling with a…

Read More
Physicists at Heidelberg University Unify Competing Quantum Models to Explain Impurity Behavior in Fermi SeasTWiV 1284: Clinical update with Dr. Daniel GriffinBrain Tumors Induce Widespread disruption of Calvarial Bone and Alteration of Skull Marrow Immune LandscapePens to pills: what oral GLP-1s change at the bench
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ